RAC 2.92% $1.94 race oncology ltd

Ann: Race Appoints George Clinical for Phase 1 Trial of RC220, page-65

  1. 69 Posts.
    lightbulb Created with Sketch. 5
    A little ridiculous that when there are so many appalling posts on HC that spout nonsense claims that are never removed, that my last post is moderated because of a fairly innocuous comment about the oncology trial landscape in Australia!!
    Given the moderator didn't like the choice of words, I will therefore rephrase it to say simply that, in my experience and speaking with others who work directly in this space, oncology trial sites in Australia are busy, it is a very competitive area. It is also a well established fact that can be backed by FDA data that completion times for many trials are often much longer than originally expected at the time of trial start.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.